With the expectation that RAE1 would also be a useful target for cancer therapy, we carried out functional studies in breast cancer cell lines and found that RAE1 contributes to aggressive cancer cell phenotype and induces EMT18. This evidence concerns the gene RAE1 and breast carcinoma.